Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD52 is a molecular target in advanced systemic mastocytosis
Gregor Hoermann, Katharina Blatt, Georg Greiner, et al.
The FASEB Journal (2014) Vol. 28, Iss. 8, pp. 3540-3551
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts
Peter Valent, Cem Akin, Dean D. Metcalfe
Blood (2016) Vol. 129, Iss. 11, pp. 1420-1427
Open Access | Times Cited: 614
Chronic mast cell leukemia: A novel leukemia-variant with distinct morphological and clinical features
Peter Valent, Karl Sotlar, Wolfgang R. Sperr, et al.
Leukemia Research (2014) Vol. 39, Iss. 1, pp. 1-5
Open Access | Times Cited: 94
Current treatment options in patients with mastocytosis: status in 2015 and future perspectives
Michel Arock, Cem Akin, Olivier Hermine, et al.
European Journal Of Haematology (2015) Vol. 94, Iss. 6, pp. 474-490
Open Access | Times Cited: 73
Midostaurin: a magic bullet that blocks mast cell expansion and activation
Peter Valent, Cem Akin, Karin Hartmann, et al.
Annals of Oncology (2017) Vol. 28, Iss. 10, pp. 2367-2376
Open Access | Times Cited: 71
Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice
Celalettin Üstün, Michel Arock, Hanneke C. Kluin‐Nelemans, et al.
Haematologica (2016) Vol. 101, Iss. 10, pp. 1133-1143
Open Access | Times Cited: 66
Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis
Katharina Blatt, Sabine Cerny‐Reiterer, Juliana Schwaab, et al.
Blood (2015) Vol. 126, Iss. 26, pp. 2832-2841
Open Access | Times Cited: 53
Single-cell sequencing exposes mast cell-derived CD52's anti-tumor action in breast cancer through the IL-6/JAK/STAT3 axis
Yueran Jia, Zhanhui Peng, Xinzhu Tian, et al.
International Journal of Biological Macromolecules (2025), pp. 142879-142879
Closed Access
Coronavirus Receptor Expression Profiles in Human Mast Cells, Basophils, and Eosinophils
Lina Degenfeld-Schonburg, Irina Sadovnik, Dubravka Smiljkovic, et al.
Cells (2024) Vol. 13, Iss. 2, pp. 173-173
Open Access | Times Cited: 4
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis
Mathias Schneeweiss‐Gleixner, Barbara Peter, Siham Bibi, et al.
Haematologica (2018) Vol. 103, Iss. 5, pp. 799-809
Open Access | Times Cited: 36
Expression and regulation of Siglec-6 (CD327) on human mast cells and basophils
Dubravka Smiljkovic, Harald Herrmann, Irina Sadovnik, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 1, pp. 202-211
Open Access | Times Cited: 17
Single-cell analysis unveils activation of mast cells in colorectal cancer microenvironment
Zhenyu Xie, Liaoran Niu, Gaozan Zheng, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
CCL2 is a KIT D816V–dependent modulator of the bone marrow microenvironment in systemic mastocytosis
Georg Greiner, Nadine Witzeneder, Angelika Berger, et al.
Blood (2016) Vol. 129, Iss. 3, pp. 371-382
Open Access | Times Cited: 27
Targeted Treatment Options in Mastocytosis
M. Vaes, Fleur Samantha Benghiat, Olivier Hermine
Frontiers in Medicine (2017) Vol. 4
Open Access | Times Cited: 27
Single-cell analysis reveals the KIT D816V mutation in haematopoietic stem and progenitor cells in systemic mastocytosis
Jennine Grootens, Johanna Ungerstedt, Maria Ekoff, et al.
EBioMedicine (2019) Vol. 43, pp. 150-158
Open Access | Times Cited: 25
Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage
Peter Valent, Jörg Berger, Sabine Cerny‐Reiterer, et al.
Annals of Hematology (2014) Vol. 94, Iss. 2, pp. 223-231
Open Access | Times Cited: 24
Preclinical human models and emerging therapeutics for advanced systemic mastocytosis
Michel Arock, Ghaith Wedeh, Gregor Hoermann, et al.
Haematologica (2018) Vol. 103, Iss. 11, pp. 1760-1771
Open Access | Times Cited: 23
Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells
Barbara Peter, Shabana Bibi, Gregor Eisenwort, et al.
Leukemia (2017) Vol. 32, Iss. 4, pp. 1016-1022
Open Access | Times Cited: 22
Clinical Validation of KIT Inhibition in Advanced Systemic Mastocytosis
John H. Baird, Jason Gotlib
Current Hematologic Malignancy Reports (2018) Vol. 13, Iss. 5, pp. 407-416
Closed Access | Times Cited: 21
CD44 is a RAS/STAT5-regulated invasion receptor that triggers disease expansion in advanced mastocytosis
Niklas Mueller, Daniel Wicklein, Gregor Eisenwort, et al.
Blood (2018) Vol. 132, Iss. 18, pp. 1936-1950
Open Access | Times Cited: 19
Developing a standardized approach for assessing mast cells and eosinophils on tissue biopsies: A Work Group Report of the AAAAI Allergic Skin Diseases Committee
Nives Zimmermann, J. Pablo Abonia, Stephen C. Dreskin, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 4, pp. 964-983
Open Access | Times Cited: 14
Antineoplastic efficacy profiles of avapritinib and nintedanib in KIT D816V+ systemic mastocytosis: a preclinical study.
Lina Degenfeld-Schonburg, Susanne Gamperl, Gabriele Stefanzl, et al.
PubMed (2023) Vol. 13, Iss. 2, pp. 355-378
Closed Access | Times Cited: 5
Tyrosine Kinase Inhibitors and Therapeutic Antibodies in Advanced Eosinophilic Disorders and Systemic Mastocytosis
Jason Gotlib
Current Hematologic Malignancy Reports (2015) Vol. 10, Iss. 4, pp. 351-361
Closed Access | Times Cited: 11
Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts
Peter Valent, Cem Akin, Michel Arock, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15125-15125
Open Access | Times Cited: 2
Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic Leukemia
Klaus Geißler, Eva Jäger, Agnes Barna, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6057-6057
Open Access | Times Cited: 5
Establishment a CHO Cell Line Expressing Human CD52 Molecule.
Khadijeh Tati, Mahsa Yazdanpanah‐Samani, Amin Ramezani, et al.
DOAJ (DOAJ: Directory of Open Access Journals) (2016) Vol. 5, Iss. 1, pp. 56-61
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top